Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers

Abstract

In primary breast cancers, trastuzumab substantially induces apoptosis, providing a molecular explanation for both its therapeutic efficacy and its successful combination with cytotoxic chemotherapy.